Search

We aimed to examine the rate and characteristics of retracted articles in infectious diseases and clinical microbiology. Using the Retraction Watch Database, we conducted a cross-sectional study for retracted publications categorized as 'Infectious Disease' or 'Microbiology' until June 30 2022. We included publications for which citation information was available through the Web of Science database. Study characteristics, retraction trends and number of citations before and after the retraction year were analysed. Overall, 1004 retracted publications were included, retracted between August 1968 and June 2022. The number of retractions climbed through the years, peaking in 2020–2021. A total of 614 retractions originated from USA, China, and India, of total 183 736 PubMed publications from these countries. Overall, 378 (38%) were retracted because of errors; 182 (18%) because of plagiarism; and 142 (14%) because of falsification/fabrication. Specific reasons included 'concerns/issues about data' (158, 16%); 'duplication of image' (127, 13%); and 'unreliable results' (116, 12%). Of the 347 retractions during 2020 to June 2022, 91 (26%) were COVID-19 related. Fifty of 895 (5.6%) first authors had two retracted papers, and 14 (1.6%) had ≥2 retractions. Of 824 publications cited at least once, 466 (57%) were cited more often after retraction. Retractions of infectious diseases and clinical microbiology publications are increasing. Concerning reasons such as plagiarism, falsification/fabrication and errors are not uncommon. Nonetheless, these publications continue to be commonly cited after being retracted. [ABSTRACT FROM AUTHOR]

COVID-19 is a buzz word nowadays. The deadly virus that started in China has spread worldwide. The fundamental principle is "if the disease can travel faster information has to travel even faster". The sequence of events reveals the upheaval need to strengthen the ability of the early warning system, risk reduction, and management of national and global risks. Digital contact tracing apps like Aarogya setu (India) and Pan-European privacy preserving proximity tracing (German) has somehow helped but they are more effective in the initial stage and less relevant in the community spread phase. Thus, there is a need to devise a Decision Support System (DSS) based on machine learning algorithms. In this paper, we have attempted to propose an Additive Utility Assumption Approach for Criterion Comparison in Multi-criterion Intelligent Decision Support system for COVID-19. The dataset of Covid-19 has been taken from government link for validating the results. In this paper, an additive utility assumption-based approach for multi-criterion decision support system (MCDSS) with an accurate prediction of identified risk factors on certain well-defined input parameters is proposed and validated empirically using the standard SEIR model approach (Susceptible, Exposed, Infected and Recovered). The results includes comparative analysis in tabular form with already existing approaches to illustrate the potential of the proposed approach including the parameters such as Precision, Recall and F-Score. Other advanced parameters such as, MCC (Matthews Correlation Coefficient), ROC (Receiver Operating Characteristics) and PRC (Precision Recall) have also been considered for validation and the graphs are illustrated using Jupyter notebook. The statistical analysis of the most affected top eight states of India is undertaken effectively using the Weka software tool and IBM Cognos software to correctly predict the outbreak of pandemic situation due to Covid-19. Finally, the article has immense potential to contribute to the COVID-19 situation and may prove to be instrumental in propelling the research interest of researchers and providing some useful insights for the current pandemic situation. • Proposing a Multi-criterion Intelligent DSS • Epidemiology modeling of data using a SEIFR Model • Our approach applies data to get trained using multiple parameters to handle and serve significant challenges existing especially in healthcare. [ABSTRACT FROM AUTHOR]

The COVID-19 outbreak has led to a substantial loss of human life throughout the world and has a tremendous impact on healthcare services. Industry 4.0 technologies have established effective supply chain management towards the fulfillment of customized demands in the healthcare field. In addition, the internet of things, artificial intelligence, big data analytics, and 3D printing have been extensively used to combat the COVID-19 pandemic and assist in providing value-added services in the healthcare sector. Henceforth, this paper presents a scientometric analysis on the literature of aforementioned Industry 4.0 technologies in the context of COVID-19. It provides extensive insights into co-citation and co-occurrence analysis of high cited publications, participating countries, influential authors, prolific journals, and keywords using the CiteSpace tool. The analyses reveal that China has produced the highest research outputs, although India is the most collaborative country in this field. The current research hotspots include supply chain, 4D printing, and social distancing technologies. Furthermore, it explores emerging trends, intellectual structure of publications, research frontiers, and potential research directions for further work in the Industry 4.0 assisted healthcare domain. [Display omitted] • Industry 4.0 technologies have emerged in the healthcare domain as an area of growing interest in academia and industry discipline. • Artificial intelligence, big data analytics, internet of things and 3D printing have been extensively used to control the COVID-19 spread and assist in providing value-added services in the healthcare sector. • It explores emerging trends, intellectual structure of publications, and potential research directions for further work in the Industry 4.0 assisted healthcare domain. [ABSTRACT FROM AUTHOR]